COVID-19
Biosimilars
Cataract Therapeutics
DME
Gene Therapy
Workplace
Ptosis
Optic Relief
Imaging
Geographic Atrophy
AMD
Presbyopia
Ocular Surface Disease
Practice Management
Pediatrics
Surgery
Therapeutics
Optometry
Retina
Cataract
Pharmacy
IOL
Dry Eye
Understanding Antibiotic Resistance
Refractive
Cornea
Glaucoma
OCT
Ocular Allergy
Clinical Diagnosis
Technology

What keeps you up at night in ophthalmology: Part II

Name: What keeps you up at night in ophthalmology: Part II
Uploaded: 2020-10-18T04:00:00.000Z
Description: Pharmaceutical representatives share what keeps them up at night within the ophthalmic space.

October 18, 2020

Alex Delaney-Gesing

Video

Conferences|GLAUCOMA 360

Pharmaceutical representatives share what keeps them up at night within the ophthalmic space.

In this second video installment, pharmaceutical representatives share what keeps them up at night within the ophthalmic and glaucoma space while attending the 2020 Glaucoma 360 meeting in San Francisco, California.

Featured: Chris Adams, Diopter Corp (CEO); Daria Lemann-Blumenthal, BELKIN Laser Ltd (CEO); Victor Chan, MB, MS, director of U.S. Surgical Device Commercial Marketing (Santen, Inc); Ramin Valian, vice president of International Glaucoma, Reimbursement and Pipeline (Allergan).

Watch the first installment here